Seizure severity and frequency during the acute stage after pilocarpine injection
| Genotype | Seizure severity | Seizure frequency (mean ± SD) | |
|---|---|---|---|
| Stage III | Stage IV | ||
| RIM1α+/+ (n = 29) | 25% | 75% | 3.1 ± 0.1 |
| RIM1α−/− (n = 23) | 31% | 69% | 3.2 ± 0.1 |
| RIM2α+/+ (n = 21) | 43% | 57% | 3.1 ± 0.2 |
| RIM2α−/− (n = 21) | 44% | 56% | 3.9 ± 0.3 |